Quick and easy tests for fungal infections in the bloodstream
Simple and rapid POC detection for fungemia
This study is working on a quick and easy test to find fungal infections in the blood, especially for people with weakened immune systems, to help doctors diagnose these infections faster and more accurately.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10749036 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid point-of-care test to detect fungal infections in the bloodstream, particularly in immunocompromised patients. It aims to improve the speed and accuracy of diagnosing infections caused by fungi like Candida and Cryptococcus, which can lead to severe health complications. The approach involves creating a user-friendly and cost-effective assay that can be used directly on patient blood samples, overcoming the limitations of current culture-based and nucleic acid amplification tests. By enhancing detection methods, the research seeks to reduce mortality rates associated with these infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include immunocompromised individuals, such as those undergoing solid organ transplants or those with severe underlying health conditions.
Not a fit: Patients who are not immunocompromised or those without risk factors for fungal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of life-threatening fungal infections, ultimately saving lives.
How similar studies have performed: Previous research has shown promise in developing rapid diagnostic tests for fungal infections, indicating that this approach could lead to significant advancements in patient care.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Alland, David — Rutgers Biomedical and Health Sciences
- Study coordinator: Alland, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.